Prelude TherapeuticsInc Correlations
| PRLD Stock | USD 4.06 0.02 0.50% |
The correlation of Prelude TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Prelude TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Prelude TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Average diversification
The correlation between Prelude TherapeuticsInc and NYA is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Prelude TherapeuticsInc and NYA in the same portfolio, assuming nothing else is changed.
Prelude |
The ability to find closely correlated positions to Prelude TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Prelude TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Prelude TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Prelude TherapeuticsInc to buy it.
Moving together with Prelude Stock
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Prelude Stock performing well and Prelude TherapeuticsInc Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Prelude TherapeuticsInc's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FHTX | 4.54 | 0.09 | 0.02 | 0.10 | 5.59 | 8.89 | 40.57 | |||
| STTK | 3.48 | (0.19) | 0.00 | (0.13) | 0.00 | 8.44 | 31.48 | |||
| GLUE | 4.52 | (0.41) | 0.00 | (0.12) | 0.00 | 9.73 | 32.99 | |||
| KYMR | 2.31 | (0.26) | 0.00 | (0.06) | 0.00 | 4.03 | 16.32 | |||
| NRIX | 4.42 | 0.61 | 0.17 | 0.20 | 3.99 | 9.80 | 36.91 | |||
| CCCC | 3.36 | (0.45) | 0.00 | (0.09) | 0.00 | 5.78 | 32.75 | |||
| ELYM | 6.71 | 2.24 | 0.41 | (0.75) | 3.93 | 20.98 | 86.31 | |||
| CYT | 0.70 | (0.02) | 0.00 | 0.13 | 0.00 | 1.64 | 4.87 | |||
| RZLT | 4.89 | 1.29 | 0.19 | 5.40 | 5.55 | 11.45 | 33.28 | |||
| MOLN | 3.17 | (0.09) | 0.00 | 0.13 | 0.00 | 5.81 | 26.69 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Prelude TherapeuticsInc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Prelude TherapeuticsInc Corporate Management
Elected by the shareholders, the Prelude TherapeuticsInc's board of directors comprises two types of representatives: Prelude TherapeuticsInc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Prelude. The board's role is to monitor Prelude TherapeuticsInc's management team and ensure that shareholders' interests are well served. Prelude TherapeuticsInc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Prelude TherapeuticsInc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Laurent MBA | Chief Officer | Profile | |
| Naveen Babbar | VP Medicine | Profile | |
| Neelesh MD | VP Devel | Profile | |
| Aimee Crombie | Senior Operations | Profile | |
| Madhu Pudipeddi | Senior Operations | Profile | |
| Lindsey Trickett | Vice Relations | Profile |
Already Invested in Prelude TherapeuticsInc?
The danger of trading Prelude TherapeuticsInc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Prelude TherapeuticsInc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Prelude TherapeuticsInc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Prelude TherapeuticsInc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Prelude TherapeuticsInc is a strong investment it is important to analyze Prelude TherapeuticsInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prelude TherapeuticsInc's future performance. For an informed investment choice regarding Prelude Stock, refer to the following important reports: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prelude TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Prelude Stock analysis
When running Prelude TherapeuticsInc's price analysis, check to measure Prelude TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prelude TherapeuticsInc is operating at the current time. Most of Prelude TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Prelude TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prelude TherapeuticsInc's price. Additionally, you may evaluate how the addition of Prelude TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Prelude TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prelude TherapeuticsInc. If investors know Prelude will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prelude TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.86) | Return On Assets (0.39) | Return On Equity (0.65) |
The market value of Prelude TherapeuticsInc is measured differently than its book value, which is the value of Prelude that is recorded on the company's balance sheet. Investors also form their own opinion of Prelude TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Prelude TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prelude TherapeuticsInc's market value can be influenced by many factors that don't directly affect Prelude TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prelude TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prelude TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prelude TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.